Home/Excellergy/Ted Jardetzky

TJ

Ted Jardetzky

Co-Founder

Therapeutic Areas

Allergic Diseases

Excellergy Pipeline

Drug	Indication	Phase
ECRI Portfolio	Severe Allergic Diseases (e.g., Asthma, Urticaria)	Pre-clinical

Leadership Team at Excellergy

Chief Executive Officer

Luke Pennington

View full Excellergy profile